Ketamine IV for the prevention of depression in the elderly: new data

Published Date: 13 Mar 2023

Intravenous (IV) ketamine is effective in adults resistant to depression. The response was similar to that seen in younger patients, two new studies show.

Read Full News

Latest News

Many Patients With B-Cell Lymphoma Miss Second-Line Care

More than 10% of patients with large B-cell lymphoma may die within a year of starting first-line treatment without ever receiving second-line therapy, a study finds.

How Obesity Affects Operating Room Procedures: Q&A

Surgeons and anesthesiologists need deeper understanding of patient’s background when obesity is at play.

ASGE Guideline: Endoscopic Management of Colonic Strictures

The American Society for Gastrointestinal Endoscopy has issued a broad-ranging update on the management of colonic strictures.

Paediatric e-Scooter Injuries Rising Sharply, Study Finds

Nearly 500 children in England were treated for e-scooter injuries over 6 years, with fewer than 2% wearing a helmet.

Thousands of US Kids Hospitalized for Vitamin Toxicity

Thousands of children have been hospitalized after poisoning by vitamins and minerals in recent years, the majority ingested intentionally.

Irinotecan Fails to Boost Rectal Cancer Outcomes

Adding irinotecan to standard chemoradiotherapy for MRI-defined, locally advanced rectal cancer did not improve disease-free survival or pathologic complete response rates but increased toxicity, including diarrhea and neutropenia.

Todays Updates

Freeman’s Lobotomy to Deep Brain Stimulation: What Changed?

The history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.

Wide Variation Seen in Lung Screening False-Positive Rates

US radiologists vary substantially in their reading of low-dose CT lung cancer screens, highlighting a need for measures to help standardize interpretation.

AVD Chemo Regimen Shows Promise in Older Patients With HL

Researchers compare first-line chemotherapy regimens in older patients with classical Hodgkin lymphoma to assess whether AVD is associated with better outcomes in routine care.

Do High-Risk Features of Prostate Cancer Boost HT Benefit?

Researchers analyze individual patient data from five randomized phase 3 trials comparing PORT alone vs PORT plus hormone therapy in patients with recurrent prostate cancer.

How Low Does PSA Need to Go in Metastatic Prostate Cancer?

A new real-world analysis helps clarify the most informative prognostic PSA benchmark in men with metastatic castration-sensitive prostate cancer.

Tissue-Free ctDNA Strongly Prognostic of Recurrence in TNBC

Tissue-free ctDNA may be comparable to tumor-informed assays in detecting molecular residual disease.

Todays Updates

Freeman’s Lobotomy to Deep Brain Stimulation: What Changed?

The history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.

Wide Variation Seen in Lung Screening False-Positive Rates

US radiologists vary substantially in their reading of low-dose CT lung cancer screens, highlighting a need for measures to help standardize interpretation.

AVD Chemo Regimen Shows Promise in Older Patients With HL

Researchers compare first-line chemotherapy regimens in older patients with classical Hodgkin lymphoma to assess whether AVD is associated with better outcomes in routine care.

Do High-Risk Features of Prostate Cancer Boost HT Benefit?

Researchers analyze individual patient data from five randomized phase 3 trials comparing PORT alone vs PORT plus hormone therapy in patients with recurrent prostate cancer.

How Low Does PSA Need to Go in Metastatic Prostate Cancer?

A new real-world analysis helps clarify the most informative prognostic PSA benchmark in men with metastatic castration-sensitive prostate cancer.

Tissue-Free ctDNA Strongly Prognostic of Recurrence in TNBC

Tissue-free ctDNA may be comparable to tumor-informed assays in detecting molecular residual disease.

Latest News

More than 10% of patients with large B-cell lymphoma may die within a year of starting first-line treatment without ever receiving second-line therapy, a study finds.

Surgeons and anesthesiologists need deeper understanding of patient’s background when obesity is at play.

The American Society for Gastrointestinal Endoscopy has issued a broad-ranging update on the management of colonic strictures.

Nearly 500 children in England were treated for e-scooter injuries over 6 years, with fewer than 2% wearing a helmet.

Thousands of children have been hospitalized after poisoning by vitamins and minerals in recent years, the majority ingested intentionally.

Adding irinotecan to standard chemoradiotherapy for MRI-defined, locally advanced rectal cancer did not improve disease-free survival or pathologic complete response rates but increased toxicity, including diarrhea and neutropenia.

News All Time

New Steroid May Spare Bone Markers Suppressed by Prednisone

Vamorolone may preserve blood markers of bone and cartilage metabolism that prednisone suppresses in boys treated for Duchenne muscular dystrophy.

Antithrombotics Not Linked to Aneurysm Rupture

In stroke patients with small incidental intracranial aneurysms, standard secondary prevention with antiplatelet or anticoagulant therapy was not linked to increased aneurysm rupture risk over nearly 30 months of follow-up.

Life or Death at 2000 Feet: Flight Nurses Work in Mid-Air

Flight nurses bring the ER with them.

Michigan Reports First US Deaths in Cyclosporiasis Outbreak

A cyclosporiasis outbreak that has grown into the largest on record in the United States has caused its first known deaths, two people in Michigan, the state's health...

Cannabinoid Hyperemesis Syndrome: A Diagnosis of Exclusion

Even the savviest ER Doc is puzzled by Cannabinoid Hyperemesis Syndrome.

Hospitalists Work Brutal Shifts. Here Are New Ways to Cope

Your body is your business in this world. Learn to take care of it so you can take care of your patients.

1 in 8 Hockey Eye Injury Diagnoses Vision-Threatening

US emergency rooms saw an estimated 6466 hockey-related ocular injury cases over a 20-year span, with a notable share being vision-threatening, a recent study shows.

NHS Radiographers Report Rising Racist Abuse

NHS radiographers report a marked rise in racist abuse from patients amid growing anti-immigrant rhetoric, the SoR says.

ROMEO Score Predicts Utility of Echocardiography in Syncope

The ROMEO score accurately identifies adults in the emergency department with syncope or presyncope who are at a low risk for clinically significant echocardiographic findings, a study finds.

Prior Overdoses Spur Carrying Naloxone in Rural Areas

Those who inject drugs or receive treatment for addiction are more likely to carry naloxone.

Routine Lumbar Puncture in Infants Under Review

A risk-stratified management and emerging biomarkers may help reduce unnecessary lumbar punctures and antibiotics while maintaining safety in febrile infants.

Prenatal Opioid Exposure Tied to Vision, ADHD Issues in Kids

A systematic review reveals that prenatal opioid exposure is linked to long-term cognitive deficits, hyperactivity, inattention, and visual impairments in school-aged children.

US FDA Approves First Freeze-dried Plasma Product

The U.S. FDA on Wednesday approved the first freeze-dried plasma product for use in the country, providing an ⁠option for patients when conventional plasma is...

Fitness to Practise Concerns Increase by a Quarter

GMC data show fitness to practise concerns rose 25% in 2025, though 90% failed to meet the threshold for a full investigation.

A&E Waits Hit Over-80s Hardest, Analysis Shows

New Nuffield Trust analysis finds over-80s in England are more than twice as likely as younger patients to face 12-hour A&E waits.

ED-Discharged Current Smokers Open to Cessation Support

Most current smokers discharged from the emergency department who are reached by automated calls express interest in quitting smoking, but only about 1 in 5 accept a Quitline referral, a study finds.

Recommended News For You

Physician Fights Insurer to Cover Her Baby's Brain Cancer Treatment

For older patients with Hodgkin lymphoma, novel regimens produce high response rates.

Gatekeeping May Reduce Pediatric Cancer Trial Participation

The pandemic had little impact on mental health symptoms.

Oncology Care Model’s Net Losses Well Exceed Savings

Prostate cancer early detection system eliminates need for biopsy.

Beyond What Is Visible in Myelofibrosis?

Recommended Articles For You

Leukemia in Focus: Tools, Trials, and Therapy Strategies for Modern Medical Practice 

Transplant Oncology and Anti-Cancer Immunosuppressants: The Evolution of a Paradigm in Cancer Care 

Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage 

Introduction to Immune Thrombocytopenic Purpura 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Early, virtual palliative care feasible for advanced lung cancer

2.

WHO launches plan for free child cancer medicines

3.

Racial differences seen in epigenetic age acceleration in childhood cancer survivors

4.

Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven

5.

After all, Pulled Myeloma Drug May Help Treat the Illness.

1.

Intelligent Hematopoietic Cell-State Mapping: Transforming Diagnostic Precision and Clinical Decision-Making

2.

Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care

3.

What Is A Normal Fibrinogen Level, And How Can It Affect Your Health

4.

Women's Health Through Understanding Hematologic Adaptation Across Menstrual and Reproductive Stages

5.

Strategic Applications in Hematology in Clinical Decision-Making

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

2.

A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer

3.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II

4.

What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot